Hirano-Sakamaki Wakako, Sugiyama Eiji, Hayasaka Takahiro, Ravid Rivka, Setou Mitsutoshi, Taki Takao
Third Institute of New Drug Discovery, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima 771-0192, Japan.
Department of Cell Biology and Anatomy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan.
FEBS Lett. 2015 Nov 30;589(23):3611-6. doi: 10.1016/j.febslet.2015.09.033. Epub 2015 Oct 17.
Alzheimer's disease (AD) is a progressive dementia associated with loss of memory and cognitive dysfunction. In a previous study, we demonstrated a decrease in b-series gangliosides along with a change in ganglioside molecular species in the hippocampal grey matter of patients with AD. The present study demonstrates the use of imaging mass spectrometry for analyzing the spatial arrangement of ganglioside GM1 (GM1) molecular species in the hippocampus. In AD patients, we found a decrease in the ratio of GM1(d20:1/C18:0) to GM1 d18:1/C18:0) in the outer molecular layer (ML) of the dentate gyrus. Because the outer ML is the region of main input into the hippocampus, our findings may have a direct relationship to the mechanism of dysfunction in AD.
阿尔茨海默病(AD)是一种与记忆丧失和认知功能障碍相关的进行性痴呆。在先前的一项研究中,我们证明了AD患者海马灰质中b系列神经节苷脂减少以及神经节苷脂分子种类发生变化。本研究展示了利用成像质谱法分析海马中神经节苷脂GM1分子种类的空间排列。在AD患者中,我们发现在齿状回外分子层(ML)中GM1(d20:1/C18:0)与GM1(d18:1/C18:0)的比例降低。由于外分子层是海马主要输入区域,我们的发现可能与AD功能障碍机制直接相关。